TB-500 Reconstitution & Storage — Research Guide

TB-500 is a synthetic 17-amino-acid fragment of the actin-binding region of thymosin beta-4 (Tβ4) supplied as a lyophilized powder for laboratory research. Correct reconstitution and storage are the single biggest determinants of measured potency, peak concentration, and inter-experiment reproducibility when working with actin-binding tissue-research peptides. This guide compiles the reconstitution ratios, diluent choices, concentration tables, storage temperatures, and stability windows most commonly cited in the published research literature.

Reconstitution Reference

| Vial Size | BAC Added | Concentration | Vol for 2 mg | Vol for 5 mg | Vol for 10 mg | | --- | --- | --- | --- | --- | --- | | 2 mg | 1.0 mL | 2.0 mg/mL | 1.00 mL (100 IU) | — | — | | 2 mg | 2.0 mL | 1.0 mg/mL | 2.00 mL (200 IU)* | — | — | | 5 mg | 1.0 mL | 5.0 mg/mL | 0.40 mL (40 IU) | 1.00 mL (100 IU) | — | | 5 mg | 2.0 mL | 2.5 mg/mL | 0.80 mL (80 IU) | — | — | | 10 mg | 2.0 mL | 5.0 mg/mL | 0.40 mL (40 IU) | 1.00 mL (100 IU) | — | | 10 mg | 4.0 mL | 2.5 mg/mL | 0.80 mL (80 IU) | — | — |

*Exceeds a single 100-IU syringe; split into two draws or use a 3 mL syringe.

Published TB-500 research dosing typically uses 2–10 mg per administration, often once or twice weekly during a loading phase followed by lower maintenance dosing.

Reconstitution Procedure

1. Equilibrate vials to room temperature.
2. Disinfect stoppers with 70% isopropanol.
3. Add BAC water slowly down the inner wall.
4. Do not shake. Swirl gently if dissolution is slow.
5. Solution should be clear and colorless within 1–3 minutes.

Storage Reference

| State | Temperature | Stability Window | | --- | --- | --- | | Lyophilized, sealed | 2–8 °C | 24 months (typical COA) | | Lyophilized, sealed | –20 °C | 36+ months | | Reconstituted in BAC | 2–8 °C | 30–45 days | | Reconstituted in SWFI | 2–8 °C | 24–72 hours | | Reconstituted, room temperature | <25 °C | 7–14 days |

Common Reconstitution Errors

• Underestimating draw volume. TB-500 doses are larger by mass than most peptides (2–10 mg vs 100–500 mcg). Choose a concentration that keeps draws within a single syringe to reduce dose-splitting error.
• Pooling weeks of doses in a single small vial. A typical 10 mg vial reconstituted at 5 mg/mL yields enough for one or two doses; pooling multiple vials into a "stock" container is not standard practice and complicates lot-traceability.
• Repeated freeze-thaw of reconstituted solution. Each cycle measurably reduces potency; aliquot if multi-day storage is required.

Concentration Worksheet

For TB-500 specifically, the dose-to-volume table is the single most useful reconstitution tool because per-administration mass varies more than for most research peptides.

Frequently Asked Questions

What diluent should be used to reconstitute TB-500? Bacteriostatic water (0.9% benzyl alcohol in sterile water) is the standard diluent across published research protocols. It preserves peptide integrity and inhibits microbial growth, supporting multi-day reuse from a single vial. Sterile water for injection (SWFI) is an acceptable alternative for single-use preparations but offers no antimicrobial protection.

How much bacteriostatic water do I add to a 10 mg vial? Reconstitution volume is a function of the desired working concentration, not a fixed rule. The concentration tables above show 2.5–5 mg/mL as the most commonly cited working range in the literature. Lower volumes give higher concentration (smaller draw volumes); higher volumes give lower concentration (larger, more accurate draw volumes for low-dose research).

How should the lyophilized powder be stored before reconstitution? Lyophilized TB-500 is stored at 2–8 °C in its original sealed vial, protected from light and moisture. For long-term storage beyond the COA's stated shelf life, –20 °C is acceptable for most research peptides. Always allow the vial to reach room temperature before opening to prevent condensation.

How long is reconstituted TB-500 stable? Refrigerated stability (2–8 °C) for solutions reconstituted in bacteriostatic water is the figure to use; specific windows are published on each batch's certificate of analysis (COA). General reference ranges from the peptide-stability literature appear in the storage table above. Avoid repeated freeze-thaw cycles, which are the most commonly cited cause of measurable potency loss.

What is the correct technique for adding diluent to the vial? Inject the bacteriostatic water slowly down the inner wall of the vial — never directly onto the lyophilized cake. Allow the powder to dissolve passively; do not shake. Gentle swirling is acceptable if dissolution is slow. Aggressive agitation introduces shear stress that can damage peptide tertiary structure.

How is dose volume calculated from the concentration table? Dose volume (mL) = research dose (mg) ÷ concentration (mg/mL). For insulin syringes marked in units (100 units = 1 mL), multiply the mL value by 100. Worked examples appear in the concentration tables above for the most common TB-500 research doses.

Can TB-500 be reconstituted in saline or other diluents? Bacteriostatic water remains the published standard. Saline reconstitution is documented in some clinical pharmacology references but is uncommon in independent research settings because it offers no preservative action. Avoid acidic or alkaline buffers unless explicitly required by an assay protocol — pH excursions accelerate peptide degradation.

What if the solution appears cloudy after reconstitution? A cloudy or particulate solution after correct reconstitution indicates either incomplete dissolution, contamination, or peptide aggregation. Do not use cloudy material for research; document the batch and request a replacement vial along with the relevant COA from the supplier.